Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 3979Pancreatic Neoplasms 2480Carcinoma, Hepatocellular 2416Stomach Neoplasms 2109Rectal Neoplasms 1676Colonic Neoplasms 1629Esophageal Neoplasms 1312Liver Neoplasms 879Neoplasms 635Breast Neoplasms 596Cholangiocarcinoma 529Gastrointestinal Neoplasms 468Neoplasm Metastasis 456Esophageal Squamous Cell Carcinoma 434Lung Neoplasms 422Biliary Tract Neoplasms 277Prostatic Neoplasms 271Ovarian Neoplasms 237Barrett Esophagus 224Adenocarcinoma Of Esophagus 202Gallbladder Neoplasms 194Head and Neck Neoplasms 186Carcinoma, Non-Small-Cell Lung 185Gastrointestinal Stromal Tumors 180Anus Neoplasms 179Recurrence 168Melanoma 163Adenocarcinoma 156Uterine Cervical Neoplasms 154Bile Duct Neoplasms 153

Interventions

toripalimab 1Sorafenib 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiotherapy × Gastrointestinal × Clear all
NCT04709380 2025-02-26

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Terminated
36 enrolled
Gastrointestinal

Radiotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡